alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › early-detection

early-detection

6 studies tagged early-detection, dated 2016-01-01 to 2025-04-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Exploring the association between mild behavioral impairment and plasma p-tau217: Implications for early detection of Alzheimer's disease 2025-04-01
  2. Serum neurofilament light chain and inflammatory cytokines as biomarkers for early detection of mild cognitive impairment 2024-04-20
  3. A blood-based multi-pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groups 2024-01-06

Studies

6 studies carry this tag.

Date range

2016 to 2025

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 2
  • Alzheimer's & dementia (Amsterdam, Netherlands) 1
  • Journal of Alzheimer's disease : JAD 1
  • Neurobiology of aging 1
  • Scientific reports 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Exploring the association between mild behavioral impairment and plasma p-tau217: Implications for early detection of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Alzheimer's & dementia (Amsterdam, Netherlands) 2025-04-01 Biomarkers

    Highlights Mild behavioral impairment (MBI) is linked to elevated plasma p-tau217, a specific Alzheimer's disease biomarker.MBI increases the odds of plasma p-tau217 positivity in dementia-free individuals.

  2. Serum neurofilament light chain and inflammatory cytokines as biomarkers for early detection of mild cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Scientific reports 2024-04-20 Biomarkers

    To investigate the association between serum neurofilament light chain (NfL) levels, inflammatory cytokines, and cognitive function to assess their utility in the early detection of mild cognitive impairment (MCI).

  3. A blood-based multi-pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groups

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024-01-06 Biomarkers

    This study demonstrated the utility of a blood-based, multi-pathway biomarker assay for early screening and staging of AD, providing insights for patient stratification and precision medicine.

  4. Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2021-09-28 Biomarkers

    ADNI has had a profound impact in improving clinical trials for AD.

  5. Blood acetylcholinesterase level is a potential biomarker for the early detection of cerebral amyloid deposition in cognitively normal individuals

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Neurobiology of aging 2018-09-08 Biomarkers

    Cerebral β-amyloid (cAβ) deposition and cholinergic dysfunction have been considered as major pathological and functional hallmarks of Alzheimer's disease (AD).

  6. Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer's Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Journal of Alzheimer's disease : JAD 2016-01-01 Biomarkers

    Visinin-like protein 1 (VILIP-1) recently emerged as a potential biomarker of Alzheimer's disease (AD).

All topic tags with their study counts